Beiersdorf’s Headline Says Decline
Its Own Sell-Out Data Says Something Else Entirely.
H1 2026: group organic sales down 3.5%. Derma organic sales up 7.8%. Two numbers from the same balance sheet, moving in opposite directions. The gap between them is the actual story management is trying to tell investors.
A 3.5% organic decline reads like a business in trouble. Look inside the number and a different picture appears. A dermatological growth engine is expanding into mass retail. International markets are accelerating by double and triple digits. A mass-market brand’s reported decline may be a retail inventory problem rather than a demand problem. Whether that distinction holds is the real question this earnings release raises.
The headline numbers
Group net sales fell 4.5% nominally and 3.5% organically to €4,952 million. The quarterly trend moderated slightly, from a 4.6% organic decline in Q1 to 2.3% in Q2. EBIT excluding special factors fell to €768 million from €836 million, a 60-basis-point margin contraction to 15.5%. Gross margin contracted 110 basis points to 58.3%. Profit after tax reached €558 million, and EPS actually rose to €2.52, helped by the ongoing share buyback programme.
The Consumer business, the core of the group, fell 4.0% organically to €4,113 million. The Tesa Industrial Adhesive Division fell 0.9% organically to €839 million in H1. It returned to growth in Q2, up 2.5%, as e-commerce tape demand strengthened. Consumer segment gross margin held at 61.0%, down 100 basis points from 62.0%. Given the scale of the volume decline, that is a smaller erosion than the headline number might suggest.
